A vet said she has lost sleep over the future of her clinic after a series of "targeted" break-ins. Dr Rachel Wallace said ...

The new excipient system, called Curablend Vet, is designed to work with CurifyLabs’ automated Compounding System Solution (CSS), an automated platform that prints the medications. Together, Curablend ...

Gerosynth Labs, Inc., a private biotechnology company pioneering novel oncology and cellular-health therapeutics, today announced that the U.S. Food and Drug Administration Center for Veterinary ...

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

CurifyLabs launches Curablend Vet for personalized pet medicines. Bringing a new level of quality and safety to veterinary ...

CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled ...

The UAE government has issued a Federal Decree-Law on Veterinary Medical Products and Veterinary Pharmaceutical Establishments. The new legislation aims to protect animal health, ensure food safety ...

CurifyLabs has announced a new veterinary excipient system that enables 3D printed, palatable, and personalised medicines for pets. Curablend Vet has been built for use with the CurifyLabs Compounding ...

It’s an injection given to canine's living with severe pain, a new leash on life. The drug is called Synovetin. It can turn ...

Vet, a new veterinary excipient system that enables 3D-printed, palatable, and personalized medicines for pets. Built for use with the CurifyLabs Compounding System Solution (CSS), Curablend Vet ...

PROVIDENCE, R.I. (WPRI) — In the year since Rhode Island’s Overdose Prevention Center opened, paramedics have been called only once — when a person overdosed on drugs laced with fentanyl, medetomidine ...

Heba Ghazal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...